NO20025461D0 - Nye formuleringer av <alfa>-(2,4-disulfofenyl)-N-tert- butylnitron - Google Patents

Nye formuleringer av <alfa>-(2,4-disulfofenyl)-N-tert- butylnitron

Info

Publication number: NO20025461D0
Authority: NO; Norway
Prior art keywords: butylnitron; disulfophenyl; tert; alpha; new formulations
Prior art date: 2000-05-23

Application number

NO20025461A

Other languages

English (en)

Other versions

NO20025461L (no

Inventor

Mats J Andersson

Mattias Andersson

Patrik Eriksson

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-05-23

Filing date

2002-11-14

Publication date

2002-11-14

2002-11-14 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2002-11-14 Publication of NO20025461L publication Critical patent/NO20025461L/no

2002-11-14 Publication of NO20025461D0 publication Critical patent/NO20025461D0/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Dermatology (AREA)
Inorganic Chemistry (AREA)
Hospice & Palliative Care (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Psychiatry (AREA)
Toxicology (AREA)
Biochemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO20025461A 2000-05-23 2002-11-14 Nye formuleringer av <alfa>-(2,4-disulfofenyl)-N-tert- butylnitron NO20025461D0 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE0001916A SE0001916D0 (sv)	2000-05-23	2000-05-23	Novel formulation
PCT/SE2001/001164 WO2001089507A1 (en)	2000-05-23	2001-05-22	NOVEL FORMULATIONS OF α-2,4-DISULFOPHENYL-N-TERT-BUTYLNITRONE

Publications (2)

Publication Number	Publication Date
NO20025461L NO20025461L (no)	2002-11-14
NO20025461D0 true NO20025461D0 (no)	2002-11-14

Family

ID=20279797

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20025461A NO20025461D0 (no)	2000-05-23	2002-11-14	Nye formuleringer av <alfa>-(2,4-disulfofenyl)-N-tert- butylnitron

Country Status (30)

Country	Link
US (2)	US20030181527A1 (no)
EP (1)	EP1294369B1 (no)
JP (1)	JP3744857B2 (no)
KR (1)	KR20030001545A (no)
CN (1)	CN1268326C (no)
AR (1)	AR030218A1 (no)
AT (1)	ATE303803T1 (no)
AU (2)	AU2001260935B2 (no)
BR (1)	BR0111055A (no)
CA (1)	CA2408781A1 (no)
CZ (1)	CZ20023849A3 (no)
DE (1)	DE60113255T2 (no)
DK (1)	DK1294369T3 (no)
EE (1)	EE200200653A (no)
ES (1)	ES2247112T3 (no)
HK (1)	HK1051649A1 (no)
HU (1)	HUP0302310A3 (no)
IL (1)	IL152533A0 (no)
IS (1)	IS6610A (no)
MX (1)	MXPA02011533A (no)
MY (1)	MY130445A (no)
NO (1)	NO20025461D0 (no)
NZ (1)	NZ522329A (no)
PL (1)	PL361284A1 (no)
RU (1)	RU2271800C2 (no)
SE (1)	SE0001916D0 (no)
SK (1)	SK16542002A3 (no)
TW (1)	TWI259078B (no)
WO (1)	WO2001089507A1 (no)
ZA (1)	ZA200208747B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20050182060A1 (en) *	2004-02-13	2005-08-18	Kelly Michael G.	2-Substituted and 4-substituted aryl nitrone compounds
US10005830B2 (en)	2009-03-05	2018-06-26	Ablynx N.V.	Antigen binding dimer-complexes, methods of making/avoiding and uses thereof
US9265834B2 (en)	2009-03-05	2016-02-23	Ablynx N.V.	Stable formulations of polypeptides and uses thereof
EP2470015B1 (en)	2009-08-24	2016-01-13	Hough Ear Institute	Nitrone compounds for treating sensorineural hearing loss
LT2805731T (lt) *	2009-09-03	2019-02-11	Ablynx N.V.	Stabilios polipeptidų kompozicijos ir jų panaudojimas
EP2512489A4 (en) *	2009-12-15	2014-04-02	Merck Sharp & Dohme	METHOD OF PREPARING ACADESINE
AU2012211989B2 (en) *	2011-02-04	2017-03-02	Hough Ear Institute	Methods for treating brain injury
EP2911648B1 (en) *	2012-10-25	2017-02-01	Fresenius Kabi Oncology Limited	Stable pharmaceutical composition of 5-aza-2'peoxyotipine
US10660851B2 (en)	2015-01-02	2020-05-26	Rxos Medical	Polyfunctional radical scavenger hydrogel formulation
CN116650411A (zh) *	2022-02-25	2023-08-29	广州喜鹊医药有限公司	一种注射用硝酮嗪药物组合物及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR960008230B1 (ko) *	1989-10-17	1996-06-21	윌리엄 쥐.씨먼	중추신경계의 산화적 손상에 관련된 질병들을 억제하기 위한 조성물들
JP2813023B2 (ja) *	1990-03-13	1998-10-22	株式会社神戸製鋼所	Ｍｉｓ型ダイヤモンド電界効果トランジスタ
US5488145A (en) *	1993-12-23	1996-01-30	Oklahoma Medical Research Foundation	2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceutical free radical traps

2000
- 2000-05-23 SE SE0001916A patent/SE0001916D0/xx unknown
2001
- 2001-05-09 AR ARP010102188A patent/AR030218A1/es not_active Application Discontinuation
- 2001-05-10 TW TW090111180A patent/TWI259078B/zh not_active IP Right Cessation
- 2001-05-21 MY MYPI20012391A patent/MY130445A/en unknown
- 2001-05-22 RU RU2002129588/15A patent/RU2271800C2/ru not_active IP Right Cessation
- 2001-05-22 WO PCT/SE2001/001164 patent/WO2001089507A1/en active IP Right Grant
- 2001-05-22 KR KR1020027015761A patent/KR20030001545A/ko active IP Right Grant
- 2001-05-22 BR BR0111055-1A patent/BR0111055A/pt not_active IP Right Cessation
- 2001-05-22 NZ NZ522329A patent/NZ522329A/en unknown
- 2001-05-22 DK DK01934785T patent/DK1294369T3/da active
- 2001-05-22 EP EP01934785A patent/EP1294369B1/en not_active Expired - Lifetime
- 2001-05-22 DE DE60113255T patent/DE60113255T2/de not_active Expired - Fee Related
- 2001-05-22 IL IL15253301A patent/IL152533A0/xx unknown
- 2001-05-22 CZ CZ20023849A patent/CZ20023849A3/cs unknown
- 2001-05-22 CA CA002408781A patent/CA2408781A1/en not_active Abandoned
- 2001-05-22 EE EEP200200653A patent/EE200200653A/xx unknown
- 2001-05-22 ES ES01934785T patent/ES2247112T3/es not_active Expired - Lifetime
- 2001-05-22 AU AU2001260935A patent/AU2001260935B2/en not_active Ceased
- 2001-05-22 AT AT01934785T patent/ATE303803T1/de not_active IP Right Cessation
- 2001-05-22 HU HU0302310A patent/HUP0302310A3/hu unknown
- 2001-05-22 PL PL36128401A patent/PL361284A1/xx not_active Application Discontinuation
- 2001-05-22 SK SK1654-2002A patent/SK16542002A3/sk unknown
- 2001-05-22 AU AU6093501A patent/AU6093501A/xx active Pending
- 2001-05-22 JP JP2001585752A patent/JP3744857B2/ja not_active Expired - Fee Related
- 2001-05-22 MX MXPA02011533A patent/MXPA02011533A/es active IP Right Grant
- 2001-05-22 CN CNB018098401A patent/CN1268326C/zh not_active Expired - Fee Related
- 2001-05-22 US US10/276,747 patent/US20030181527A1/en not_active Abandoned
2002
- 2002-10-29 ZA ZA200208747A patent/ZA200208747B/en unknown
- 2002-11-11 IS IS6610A patent/IS6610A/is unknown
- 2002-11-14 NO NO20025461A patent/NO20025461D0/no unknown
2003
- 2003-05-30 HK HK03103875A patent/HK1051649A1/xx not_active IP Right Cessation
2007
- 2007-10-12 US US11/974,504 patent/US20080161406A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CZ20023849A3 (cs)	2003-05-14
KR20030001545A (ko)	2003-01-06
US20080161406A1 (en)	2008-07-03
JP2003534276A (ja)	2003-11-18
SE0001916D0 (sv)	2000-05-23
AU2001260935B2 (en)	2005-05-19
DE60113255T2 (de)	2006-06-08
NO20025461L (no)	2002-11-14
CN1268326C (zh)	2006-08-09
ES2247112T3 (es)	2006-03-01
DK1294369T3 (da)	2005-11-14
IS6610A (is)	2002-11-11
RU2271800C2 (ru)	2006-03-20
TWI259078B (en)	2006-08-01
CN1430510A (zh)	2003-07-16
NZ522329A (en)	2004-07-30
BR0111055A (pt)	2003-04-15
JP3744857B2 (ja)	2006-02-15
ATE303803T1 (de)	2005-09-15
CA2408781A1 (en)	2001-11-29
PL361284A1 (en)	2004-10-04
EE200200653A (et)	2004-06-15
RU2002129588A (ru)	2004-03-27
WO2001089507A1 (en)	2001-11-29
MY130445A (en)	2007-06-29
HK1051649A1 (en)	2003-08-15
MXPA02011533A (es)	2003-04-25
EP1294369A1 (en)	2003-03-26
SK16542002A3 (sk)	2003-04-01
HUP0302310A2 (hu)	2003-11-28
AU6093501A (en)	2001-12-03
EP1294369B1 (en)	2005-09-07
DE60113255D1 (de)	2005-10-13
AR030218A1 (es)	2003-08-13
ZA200208747B (en)	2004-02-10
US20030181527A1 (en)	2003-09-25
HUP0302310A3 (en)	2005-06-28
IL152533A0 (en)	2003-05-29

Publication	Publication Date	Title
NO20033715L (no)	2002-04-30	Nye sammensetninger
NO20005832D0 (no)	2000-11-17	Nye spesielle formuleringer
IS6709A (is)	2003-02-06	Fljótandi samsetningar metformíns
NO20026064L (no)	2003-02-17	Nye forbindelser
ID30590A (id)	2002-01-03	Celana sekali pakai jenis-celana pendek
NO20023934L (no)	2002-10-07	Nye forbindelser
DE60234409D1 (de)	2009-12-31	Säuregenerator, Sulfonsäure, Sulfonsäurederivate und strahlungsempfindliche Zusammensetzung
IT1319645B1 (it)	2003-10-23	Base cristallina di citalopram.
NO20024528L (no)	2002-11-19	Proteaseinhibitor, farmasoytisk sammensetning og anvendelse av forbindelsen
DK1170288T3 (da)	2004-11-29	Diphenylurinstofderivater og deres anvendelse som alfa2/5-HT2c-antagonister
NO20015074L (no)	2001-11-15	Nye sammensetninger
NO20031141D0 (no)	2003-03-12	Nye forbindelser
NO20025461D0 (no)	2002-11-14	Nye formuleringer av <alfa>-(2,4-disulfofenyl)-N-tert- butylnitron
NO20026162D0 (no)	2002-12-20	Nye forbindelser
DE60142051D1 (de)	2010-06-17	Herstellung von perfluorolefinen
NO20026081D0 (no)	2002-12-18	Nye forbindelser
DK1204659T3 (da)	2004-04-05	Serotonerge benzofuraner
AR028607A1 (es)	2003-05-14	Derivados de 1,4-diazepan-2,5-diona
NO20011664D0 (no)	2001-04-03	Sammensetning med höy renhet omfattende (7<alfa>, 17<alfa>)- 17-hydroksy-7-metyl-19-nor-17-pregn-5(10)-en-20-yn-3-on
IT1317861B1 (it)	2003-07-15	Uso di composti fluorurati per conferire proprieta' release.
DE60100043D1 (de)	2002-12-19	Zusammensetzung von Poly-1-Butenharz und die Zusammensetzung enthaltendes Wasserrohr
NO20004513D0 (no)	2000-09-08	Oksygenering av sjøvann
NO20025902D0 (no)	2002-12-09	Nye fenylpiperaziner
NO20030419D0 (no)	2003-01-27	16<alfa>-metyl- eller etyl-substituerte estrogener
NO20033073D0 (no)	2003-07-04	Farmasöytisk sammensetning inneholdende citalopram